| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 06/08/2000 | WO2000032570A1 Hydrazine derivatives |
| 06/08/2000 | CA2352878A1 Antitumor dibenzofluorene derivatives |
| 06/08/2000 | CA2352367A1 Nonsteroidal antiinflammatories |
| 06/08/2000 | CA2351321A1 Hydrazine derivatives |
| 06/07/2000 | EP1005356A1 Novel antibacterial agents |
| 06/07/2000 | CN1255919A Efficient enantioselective addition reaction using organozinc reagent |
| 06/07/2000 | CN1255496A Application of heterobicyclic alcohol antimer for preparing piperazine derivative |
| 06/06/2000 | US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases |
| 06/06/2000 | US6071901 Treating pain, hyperalgesia and/or inflammatory conditions in which c-fibers play a pathophysiological role; inhibition of neurogenic inflammation involving the release of neuro-peptide from peripheral and central endings of sensory nerves |
| 06/06/2000 | US6071895 Polar-substituted hydrocarbons |
| 06/02/2000 | WO2000031036A1 Novel naphthalene derivatives |
| 05/31/2000 | EP1003758A2 Solution phase synthesis of oligonucleotides |
| 05/31/2000 | EP1003736A1 Substituted 4-benzoyl-pyrazoles |
| 05/31/2000 | EP1003730A1 2-benzoyl-cyclohexane-1,3-diones |
| 05/31/2000 | EP1003541A1 Inhibitors of hiv reverse transcriptase |
| 05/31/2000 | EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 05/31/2000 | EP1003491A1 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases |
| 05/31/2000 | DE19856475A1 Nichtsteroidale Entzündungshemmer Nonsteroidal anti-inflammatory drugs |
| 05/31/2000 | CN1254596A Process for preparing composition to kill internal parasites |
| 05/24/2000 | CN1253954A Heterocyclic alkoxyl amine as regulator in controlled free radical polymerization method |
| 05/18/2000 | WO2000027820A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 05/18/2000 | WO2000027819A2 Antrhranilic acid amides and the use thereof as medicaments |
| 05/18/2000 | WO2000027808A1 N-arylsulfonyl amino acid omega amides |
| 05/18/2000 | WO2000009479A3 Heterocyclic thioesters or ketones for vision and memory disorders |
| 05/18/2000 | WO2000007979A3 Compounds and compositions for delivering active agents |
| 05/18/2000 | CA2350208A1 Antrhranilic acid amides and the use thereof as medicaments |
| 05/18/2000 | CA2346898A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 05/11/2000 | WO2000026214A1 Linear process for the preparation of a morpholine compound |
| 05/11/2000 | WO2000026200A1 An improved process for the preparation of new antidiabetic agents |
| 05/11/2000 | WO2000026199A2 Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists |
| 05/11/2000 | WO2000026198A1 N-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives, their preparation and their use as selective mglur1 antagonists |
| 05/11/2000 | DE19851184A1 N-Arylsulfonyl-aminosäure-omega-amide N-arylsulfonyl-amino-omega-amides |
| 05/11/2000 | CA2349482A1 Pharmaceutical compounds |
| 05/11/2000 | CA2346941A1 An improved process for the preparation of new antidiabetic agents |
| 05/10/2000 | EP0999208A1 Nitrogenous heterocyclic compounds and hyperlipemia remedy containing the same |
| 05/10/2000 | EP0998451A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 05/10/2000 | EP0685234B1 Drug composition containing nucleic acid copolymer |
| 05/10/2000 | CN1252799A N-heterocyclic derivatives as NOS inhibitor |
| 05/10/2000 | CN1252690A Fungicide active substance combinations |
| 05/09/2000 | US6060493 Phenyl benzyl ethers, process for producing them and their use as pesticide and fungicide |
| 05/04/2000 | WO2000024723A1 Stabilization of the reagent dimethyl titanocene |
| 05/04/2000 | WO2000024722A1 2,3-dihydro-4-oxo-4h-1,3-oxazine and 2-oxo-1,2,5,6-tetrahydropyridine derivatives and their use as herbicides |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/04/2000 | WO1999063988A9 Inhibitors of nitric oxide synthase |
| 05/04/2000 | WO1999062888A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 05/03/2000 | EP0736031B1 Improvements in or relating to chiral syntheses |
| 05/03/2000 | CN1252064A Bicyclic amino acids |
| 05/02/2000 | US6057371 Sigma receptor ligands and the use thereof |
| 05/02/2000 | US6057320 Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| 04/27/2000 | WO2000023421A1 (SUBSTITUTED)ACYL DIPEPTIDYL INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | CA2347792A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/26/2000 | CN1251582A Asymmetric synthesis of benzoxazinones via new intermediates |
| 04/26/2000 | CN1051768C 1,3-oxazine-4-one derivatives, its preparation method and use as herbicides |
| 04/26/2000 | CN1051767C Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 04/25/2000 | US6054453 Hypolipidemic, antihyperglycemic uses. |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | DE19949352A1 Heterocyclic alkoxyamine polymerization composition useful as regulator in free-radical polymerization to obtain low-polydispersity polymeric resins |
| 04/19/2000 | EP0994110A1 Sulphonamide derivatives |
| 04/19/2000 | CN1250652A Compositions contg. benzoxazinone and nucleoside like materials |
| 04/18/2000 | US6051707 Linear process for the preparation of a morpholine compound |
| 04/18/2000 | US6051573 Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists |
| 04/16/2000 | CA2286375A1 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes |
| 04/12/2000 | EP0605726B1 1,3-oxazin-4-one derivative, herbicide containing the same, and novel intermediate for producing the same |
| 04/11/2000 | US6048859 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 04/06/2000 | DE19845298A1 New N-oxyl radicals for use in the controlled polymerisation of unsaturated monomers, especially acrylate esters, comprise N-oxides of 5-morpholone derivatives with organic substituents at positions two and six |
| 04/05/2000 | EP0989857A1 Novel therapeutic agents that modulate enzymatic processes |
| 04/05/2000 | EP0740791A4 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties |
| 04/05/2000 | CN1051081C Method for preparing inclusion complexes of 3-morpholino-sydnonimine |
| 04/05/2000 | CN1051080C Method for preparing pharmaceutical composition contg. substd. sydnonimine or salts |
| 04/04/2000 | US6046368 Catalytic process for making hydrofluoroethers |
| 04/04/2000 | US6046325 Chemical synthesis of 1,4-oxazin-2-ones |
| 04/04/2000 | US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/04/2000 | US6046193 Treatment of attention-deficit/hyperactivity disorder |
| 04/04/2000 | US6046190 For inhibiting retroviral proteases such as human immunodeficiency virus |
| 04/04/2000 | US6046135 For controlling weeds |
| 04/04/2000 | CA2015242C Heterocyclic diones as pesticides and plant growth regulators |
| 03/30/2000 | WO2000017173A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 03/30/2000 | WO2000017172A1 Herbicides containing benzoxazine derivatives |
| 03/30/2000 | WO2000016603A2 Bridged heterocyclic derivatives |
| 03/30/2000 | CA2344376A1 Bridged heterocyclic derivatives |
| 03/30/2000 | CA2341170A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 03/29/2000 | CN1248969A Process for preparing N-alkyl ammonium acetonitrile compounds |
| 03/28/2000 | CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| 03/28/2000 | CA2001003C Olefinically unsaturated compounds, a process for the production of copolymers containing isocyanate groups, the copolymers thus obtained and coating compositions or sealing compounds containing the copolymers |
| 03/25/2000 | WO1999014206A1 Morpholinones as light stabilizers |
| 03/25/2000 | CA2297208A1 Morpholinones as light stabilizers |
| 03/23/2000 | WO2000015621A1 Process for the synthesis of n-benzyl-3-(4-fluorophenyl)-1,4-oxazin-2-one |
| 03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 03/23/2000 | DE19844291A1 New aminoalkylaminoalkyl-substituted benzoxazines or benzothiazines, are nitrogen monoxide synthase inhibitors useful for treating neurodegenerative, inflammatory, autoimmune or cardiovascular disease |
| 03/23/2000 | CA2342213A1 Process for the synthesis of n-benzyl-3-(4-fluorophenyl)-1,4-oxazin-2-one |
| 03/22/2000 | EP0986545A1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity |
| 03/22/2000 | EP0986384A1 Inhibitors of protein isoprenyl transferases |
| 03/22/2000 | EP0804537B1 Cleaning process and composition |
| 03/21/2000 | US6040482 Produced in a single step by reacting an oxyalkylene oxide or oxyalkylester having from 3 to 12 carbon atoms, glycidol, or a glycidyl with an aminophenol without the use of a catalyst and at low temperatures; xanthene, coumarin dyes |
| 03/21/2000 | US6040480 Preparing 2-(1,1,1-trifluoro-2-hydroxy-4-cyclopropyl-but-3-yn-2-yl),4-chloroaniline; cyclization; human immunodeficiency virus (hiv) reverse transcriptase inhibitor nontoxic maaterials; nonchromagraphic purification |
| 03/21/2000 | US6040443 Reacting an ortho-hydroxybenzamide derivative with benzoyl chloride derivative at elevated temperature, heating in absence of external solvent, until a melt is formed |
| 03/21/2000 | US6040339 Treatment and prophylaxis of hypercholesteremia or arteriosclerosis in a mammal |
| 03/16/2000 | WO2000014063A1 Therapeutic compounds and methods |